These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1714563)

  • 41. Respective role of each of the purine N-6 amino groups of 5'-O-triphosphoryladenylyl(2'----5')adenylyl(2----5')adenosine in binding to and activation of RNase L.
    Imai J; Lesiak K; Torrence PF
    J Biol Chem; 1985 Feb; 260(3):1390-3. PubMed ID: 2981855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A route to 2',5'-oligoadenylates with increased stability towards phosphodiesterases.
    Itkes AV; Karpeisky MYa ; Kartasheva ON; Mikhailov SN; Moiseyev GP; Pfleiderer W; Charubala R; Yakovlev GI
    FEBS Lett; 1988 Aug; 236(2):325-8. PubMed ID: 2842187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biologically stable 2-5A analogues containing 3'-O,4'-C-bridged adenosine as potent RNase L agonists.
    Morita K; Kaneko M; Obika S; Imanishi T; Kitade Y; Koizumi M
    ChemMedChem; 2007 Dec; 2(12):1703-7. PubMed ID: 17910011
    [No Abstract]   [Full Text] [Related]  

  • 44. Efficient functionalization of 2',5'-oligoadenylates with sulfur.
    Lesiak K; Torrence PF
    Bioconjug Chem; 1997; 8(2):199-203. PubMed ID: 9095361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological activities of a phosphorodithioate analog of 2',5'-oligoadenylate.
    Beigelman L; Matulic-Adamic J; Haeberli P; Usman N; Dong B; Silverman RH; Khamnei S; Torrence PF
    Nucleic Acids Res; 1995 Oct; 23(19):3989-94. PubMed ID: 7479047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and biological activity of 5'-capped derivatives of 5'-triphosphoadenylyl(2'----5')adenylyl(2'----5')adenosine.
    Imai J; Torrence PF
    Biochemistry; 1984 Feb; 23(4):766-74. PubMed ID: 6712921
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemical synthesis of 2',5'-oligoadenylate analogues.
    Charubala R; Pfleiderer W
    Prog Mol Subcell Biol; 1994; 14():114-38. PubMed ID: 7520327
    [No Abstract]   [Full Text] [Related]  

  • 48. Oligonucleotide structural parameters that influence binding of 5'-O-triphosphoadenylyl-(2'----5')-adenylyl-(2'----5')-adenosine to the 5'-O-triphosphoadenylyl-(2'----5')-adenylyl-(2'----5')-adenosine dependent endoribonuclease: chain length, phosphorylation state, and heterocyclic base.
    Torrence PF; Imai J; Lesiak K; Jamoulle JC; Sawai H
    J Med Chem; 1984 Jun; 27(6):726-33. PubMed ID: 6737414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and properties of second-generation 2-5A-antisense chimeras with enhanced resistance to exonucleases.
    Li G; Xiao W; Torrence PF
    J Med Chem; 1997 Aug; 40(18):2959-66. PubMed ID: 9288179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Photochemical crosslinking in oligonucleotide-protein complexes between a bromine-substituted 2-5A analog and 2-5A-dependent RNase by ultraviolet lamp or laser.
    Nolan-Sorden NL; Lesiak K; Bayard B; Torrence PF; Silverman RH
    Anal Biochem; 1990 Feb; 184(2):298-304. PubMed ID: 2327573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system.
    Castelli JC; Hassel BA; Wood KA; Li XL; Amemiya K; Dalakas MC; Torrence PF; Youle RJ
    J Exp Med; 1997 Sep; 186(6):967-72. PubMed ID: 9294150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 2-5A induces a conformational change in the ankyrin-repeat domain of RNase L.
    Nakanishi M; Goto Y; Kitade Y
    Proteins; 2005 Jul; 60(1):131-8. PubMed ID: 15849753
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Solid-phase synthesis of 5'-triphosphate 2'-5'-oligoadenylates analogs with 3'-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs.
    Thillier Y; Stevens SK; Moy C; Taylor J; Vasseur JJ; Beigelman L; Debart F
    Bioorg Med Chem; 2013 Sep; 21(17):5461-9. PubMed ID: 23810677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The 2-5A/RNase L pathway and inhibition by RNase L inhibitor (RLI).
    Bisbal C; Salehzada T; Silhol M; Martinand C; Le Roy F; Lebleu B
    Methods Mol Biol; 2001; 160():183-98. PubMed ID: 11265282
    [No Abstract]   [Full Text] [Related]  

  • 55. Synthesis and biological activity of a fluorescent analogue of 2-5A.
    Lesiak K; Torrence PF
    FEBS Lett; 1983 Jan; 151(2):291-6. PubMed ID: 6832358
    [No Abstract]   [Full Text] [Related]  

  • 56. Using fluorescence resonance energy transfer (FRET) for measuring 2-5A analogues ability to activate RNase L.
    Cramer H; Geselowitz DA; Torrence PF
    Nucleosides Nucleotides; 1999; 18(6-7):1523-5. PubMed ID: 10474231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discrimination between ribonuclease H- and ribonuclease L-mediated RNA degradation by 2'-O-methylated 2-5A-antisense oligonucleotides.
    Cramer H; Player MR; Torrence PF
    Bioorg Med Chem Lett; 1999 Apr; 9(7):1049-54. PubMed ID: 10230638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biological activities of phosphodiester linkage isomers of 2-5A.
    Lesiak K; Imai J; Floyd-Smith G; Torrence PF
    J Biol Chem; 1983 Nov; 258(21):13082-8. PubMed ID: 6630222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phosphorothioate analogues of 2',5'-oligoadenylate. Activation of 2',5'-oligoadenylate-dependent endoribonuclease by 2',5'-phosphorothioate cores and 5'-monophosphates.
    Karikó K; Li SW; Sobol RW; Suhadolnik RJ; Charubala R; Pfleiderer W
    Biochemistry; 1987 Nov; 26(22):7136-42. PubMed ID: 3427063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A convenient and sensitive fluorescence resonance energy transfer assay for RNase L and 2',5' oligoadenylates.
    Thakur CS; Xu Z; Wang Z; Novince Z; Silverman RH
    Methods Mol Med; 2005; 116():103-13. PubMed ID: 16000857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.